CD38 and neoplasm: The NCI-H929 tumor xenograft model was used to evaluate the efficacy of the CD38/CD47 BsAbs, including IMM5605-ISA, IMM5605-DARA, IMM5605–4A8, 12C10, 26B4, 35G5, and 65A7.